A CB1/CB2 receptor agonist, WIN 55,212-2, exerts its therapeutic effect in a viral autoimmune model of multiple sclerosis by restoring self-tolerance to myelin-Reference-Cited by-同舟云学术

A CB1/CB2 receptor agonist, WIN 55,212-2, exerts its therapeutic effect in a viral autoimmune model of multiple sclerosis by restoring self-tolerance to myelin

Published:2012-09 Issue:3 Volume:63 Page:385-393
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Arevalo-Martin Angel,Molina-Holgado Eduardo,Guaza Carmen

Funder

Gobierno de Castilla-La Mancha

Spanish Ministerio de Ciencia e Innovacion

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference50 articles.

1. Therapeutic action of cannabinoids in a murine model of multiple sclerosis;Arevalo-Martin;J. Neurosci.,2003

2. The endocannabinoid system and multiple sclerosis;Baker;Curr. Pharm. Des.,2008

3. Cannabinoids control spasticity and tremor in a multiple sclerosis model;Baker;Nature,2000

4. Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis;Benito;J. Neurosci.,2007

5. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis;Cabranes;Neurobiol. Dis.,2005

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cannabinoid WIN55,212-2 reprograms monocytes and macrophages to inhibit LPS-induced inflammation;Frontiers in Immunology;2023-03-16

2. Role of omega-3 endocannabinoids in the modulation of T-cell activity in a multiple sclerosis experimental autoimmune encephalomyelitis (EAE) model;Journal of Biological Chemistry;2023-02

3. Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders;Frontiers in Psychiatry;2022-06-14

4. Phytocannabinoids and Cannabis-Based Products as Alternative Pharmacotherapy in Neurodegenerative Diseases: From Hypothesis to Clinical Practice;Frontiers in Cellular Neuroscience;2022-05-30

5. Neurological Benefits, Clinical Challenges, and Neuropathologic Promise of Medical Marijuana: A Systematic Review of Cannabinoid Effects in Multiple Sclerosis and Experimental Models of Demyelination;Biomedicines;2022-02-24